Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Pfizer (PFE), Bristol Myers Squibb (BMY)
- Julie catches up with participants of the big pharma-sponsored New York AIDS Walk.
- Videos 2008-05-21
- Wallstrip: The Female Health Company (FHC)
- The Female Health Company manufactures, markets, and sells the female condom.
- Videos 2008-11-12
- The Female Health Company (FHC)
- The Female Health Company manufactures, markets, and sells the female condom.
- Videos 2008-11-12
Additional Resources
- Point-of-Care HIV Testing Using Simple/Rapid HIV Test Kits: Guidance for Health-Care Professionals
- The purpose of this document is to provide clinical and technical information that will help Canadian health-care professionals to implement point-of-care HIV testing with the use of simple/rapid HIV test kits. Simple/rapid HIV test kits were first licensed for use in approved HIV testing laboratories in April 1998 and are...
- White papers 2000-04-01
- Access to HIV Care: Initial Results From the HIV Cost and Services Utilization Study
- This paper discusses and gives information on HIV care across all regions of America. Recent clinical advances have made HIV/AIDS a highly treatable disease. Appropriate medical care can prolong the lives of HIV-infected individuals and prevent unnecessary and potentially costly complications. However, not all HIV-infected individuals have sufficient access to...
- White papers
- HIV Prevention Community Planning Guidance
- This Guidance for HIV Prevention Community Planning defines the Centers for Disease Control and Prevention's CDC expectations of health departments and HIV prevention community planning groups CPGs in implementing HIV prevention community planning. The HIV Prevention Community Planning Guidance provides a blue-print for HIV prevention planning and provides flexible direction...
- White papers 2003-08-22
- ViiV chief vows joint venture will help battle HIV
- The new head of the pioneering HIV joint venture between GlaxoSmithKline and Pfizer predicts his company can operate for at least five years without fresh funding from its shareholders. Dominique Limet, chief executive of ViiV Healthcare, which was formally launched yesterday, says it will generate £1.6bn a year in sales...
- News items 2009-11-04
- Chembio Submits Two HIV Rapid Tests to the FDA for Pre-Market Approval; Products Also Qualified for USAID and UN Global Fund Procurements
- MEDFORD, NY -- Chembio Diagnostics, Inc. (OTCBB:CEMI) today announced that it submitted an application to the U.S. Food and Drug Administration FDA for Pre-Market Approval of its Sure CheckTM HIV and HIV Stat-Pak rapid HIV tests. Both Sure Check HIV and HIV Stat-Pak are rapid test devices that can detect...
- Research articles 2005-02-22
- Merck's ISENTRESS® Tablets in Combination with other Anti-HIV Medicines Maintained Reductions in HIV-1 Viral Load and Increased CD4 Cell Counts Through 48 Weeks of Therapy in Treatment-Experienced Adults
- BOSTON -- ISENTRESS([R]) raltegravir tablets, Merck's HIV integrase inhibitor, in combination with other anti-HIV medicines, maintained significant HIV-1 viral load suppression and increased CD4 cell counts through 48 weeks of therapy compared to placebo in combination with anti-HIV medicines, in two Phase III studies of 699 treatment-experienced patients failing antiretroviral...
- Research articles 2008-02-06
- US DEPT OF HHS: NIAID study -- Rapid rebound of HIV an and reappearance of HIV.
- M2 PRESSWIRE-28 October 1999-US DEPT OF HHS: NIAID study -- Rapid rebound of HIV and reappearance of HIV C1994-99 M2 COMMUNICATIONS LTD RDATE:271099 * Reservoirs in patients treated with IL-2 and combination antiretroviral drugs following cessation of therapy In...
- Research articles 1999-10-28
- US DEPT OF HHS: High HIV RNA levels major risk fa factor for mother-to-child HIV transmission.
- M2 PRESSWIRE-5 August 1999-US DEPT OF HHS: High HIV RNA levels major risk factor for mother-to-child HIV transmission C1994-99 M2 COMMUNICATIONS LTD RDATE:040899 Two studies supported by the National Institutes of Health NIH provide compelling evidence that the amount of HIV...
- Research articles 1999-08-05
- The Governor's Council on HIV/AIDS To Meet at WestCoast Sea-Tac Hotel
- OLYMPIA, Wash.--BUSINESS WIRE--Nov. 6, 1998--The Governor's Council on HIV/AIDS will meet Nov. 10, 9:30 a.m. to 3 p.m. at the WestCoast Sea-Tac Hotel. The meeting is open to the general public wishing to testify on HIV/AIDS issues. The Governor's Advisory Council on HIV/AIDS advises the governor on state policies...
- Research articles 1998-11-06
- HHS Awards $21.5 Million to Develop HIV Prevention Methods, Provide Treatment for People With HIV/AIDS
- WASHINGTON, Sept. 30 /U.S. Newswire/ -- HHS Secretary Tommy G. Thompson today announced 58 grants totaling more than $21.5 million to develop, implement and evaluate HIV prevention approaches and provide treatment for people living with HIV/AIDS. WASHINGTON, Sept. 30 /U.S. Newswire/ -- HHS Secretary Tommy G. Thompson today announced 58...
- Research articles 2003-09-30
- Chembio Receives FDA Approvable Letter for its Rapid HIV Tests; Major Hurdle for U.S. Sales and Eventual Over the Counter Sales Cleared
- MEDFORD, N.Y. -- Chembio Diagnostics, Inc. (OTCBB:CEMI) has received an "approvable" letter from the U.S. Food and Drug Administration FDA for its SURE CHECKR HIV 1/2 and HIV 1/2 STAT-PAKTM rapid test Pre-Market Applications PMAs. The rapid HIV tests detect HIV-1 and HIV-2 antibodies in four different sample matrices; finger-stick...
- Research articles 2006-04-19
- WHO/UNAIDS welcomes G-8 endorsement of the Global HIV Vaccine Enterprise.
- M2 PRESSWIRE-14 June 2004-WORLD BANK: WHO/UNAIDS welcomes G-8 endorsement of the Global HIV Vaccine EnterpriseC1994-2004 M2 COMMUNICATIONS LTD RDATE:06112004 Geneva -- The World Health Organization WHO and the Joint United Nations Programme on HIV/AIDS UNAIDS today welcomed the G-8's endorsement...
- Research articles 2004-06-14
- US DEPT OF HHS: New anti-HIV therapies needed to eradicate HIV.
- M2 PRESSWIRE-27 May 1999-US DEPT OF HHS: New anti-HIV therapies needed to eradicate HIV C1994-99 M2 COMMUNICATIONS LTD RDATE:260599 Currently approved anti-HIV drug combinations are remarkably effective at reducing the amount of HIV in many patients to undetectable blood levels. For...
- Research articles 1999-05-27
- World Bank to commit USD500 million more to fight HIV/AIDS in Africa; New support will reach more countries and sub-regional HIV/AIDS programs.
- M2 PRESSWIRE-8 February 2002-WORLD BANK: World Bank to commit USD500 million more to fight HIV/AIDS in Africa; New support will reach more countries and sub-regional HIV/AIDS programs C1994-2002 M2 COMMUNICATIONS LTD RDATE:08022002 Also Available in French WASHINGTON --...
- Research articles 2002-02-08
- A New Approach to Halting HIV Infection.
- Byline: Tulane University NEW ORLEANS, Feb. 6 AScribe Newswire -- Researchers at the Tulane National Primate Research Center are making strides in the fight against HIV infection, taking a new approach to halting the HIV epidemic. In the 1980s, most HIV vaccine research concentrated...
- Research articles 2004-02-06
- National Experts Retreat from Estimate of 40,000 New US HIV Infections Annually
- Still No Date Given for Release of Crucial Data Expected to Show Far Higher Incidence; AHF to Press White House for CDC's Release of New HIV Numbers WASHINGTON -- In a community forum and conference call hosted today by the Federal AIDS Policy Partnership FAPP to discuss HIV incidence...
- Research articles 2008-04-15
- HIV/AIDS in Europe; moving from death sentence to chronic disease management
- HIV/AIDS in Europe; moving from death sentence to chronic disease management. Ed. by Srdan Matic et al. World Health Organization 2006 274 pages $45.00 Paperback RC606 Fifteen contributions, presented by staff of the World Health Organization Regional Office for Europe, provide diverse...
- Research articles 2006-03-01
- << Previous
- page 1 of 1
- Next >>



